Rockwell Medical Inc reports results for the quarter ended June 30 - Earnings Summary

• Rockwell Medical Inc RMTI.OQ reported a quarterly adjusted loss of 5 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 1 cents. The mean expectation of two analysts for the quarter was for a loss of 5 cents per share.

• Revenue fell 37.8% to $16.07 million from a year ago; analysts expected $16.33 million.

• Rockwell Medical Inc's reported EPS for the quarter was a loss of 5 cents​.

• The company reported a quarterly loss of $1.49 million.

• Rockwell Medical Inc shares had risen by 23.2% this quarter and lost 48.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 25% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Rockwell Medical Inc is $4.00, about 73.9% above its last closing price of $1.05

This summary was machine generated from LSEG data August 14 at 11:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)